Literature DB >> 9645507

Cholesterol, endothelial function and cardiovascular disease.

I B Wilkinson1, J R Cockcroft.   

Abstract

Hypercholesterolaemia is associated with endothelial dysfunction and increased risk of atheromatous disease. Although endothelial dysfunction has been demonstrated early in the course of the disease process, it remains difficult to establish a causal relationship. Despite this, endothelial function has been used as a surrogate marker in small trials to identify and assess the effectiveness of therapeutic interventions to reduce cardiovascular mortality, before large scale clinical trials are undertaken. Recently, arterial stiffness has emerged as an independent risk factor for cardiovascular disease and may provide a link between hypercholesterolaemia, endothelial dysfunction, hypertension and stroke.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9645507     DOI: 10.1097/00041433-199806000-00009

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  12 in total

Review 1.  The latest generation of beta-blockers: new pharmacologic properties.

Authors:  Michala E Pedersen; John R Cockcroft
Journal:  Curr Hypertens Rep       Date:  2006-08       Impact factor: 5.369

2.  Relationship of dietary cholesterol to blood pressure: the INTERMAP study.

Authors:  Masaru Sakurai; Jeremiah Stamler; Katsuyuki Miura; Ian J Brown; Hideaki Nakagawa; Paul Elliott; Hirotsugu Ueshima; Queenie Chan; Ioanna Tzoulaki; Alan R Dyer; Akira Okayama; Liancheng Zhao
Journal:  J Hypertens       Date:  2011-02       Impact factor: 4.844

Review 3.  Biomedical applications of zinc oxide nanomaterials.

Authors:  Y Zhang; T R Nayak; H Hong; W Cai
Journal:  Curr Mol Med       Date:  2013-12       Impact factor: 2.222

4.  Reference values for the augmentation index and pulse pressure in apparently healthy korean subjects.

Authors:  Jin Wook Chung; Young Soo Lee; Jeong Hyun Kim; Myung Jun Seong; So Yeon Kim; Jin Bae Lee; Jae Kean Ryu; Ji Yong Choi; Kee Sik Kim; Sung Gug Chang; Geon Ho Lee; Sung Hi Kim
Journal:  Korean Circ J       Date:  2010-04-22       Impact factor: 3.243

5.  A combined oral contraceptive containing 30 mcg ethinyl estradiol and 3.0 mg drospirenone does not impair endothelium-dependent vasodilation.

Authors:  Jessica R Meendering; Britta N Torgrimson; Nicole P Miller; Paul F Kaplan; Christopher T Minson
Journal:  Contraception       Date:  2010-04-27       Impact factor: 3.375

6.  Cholesterol-Induced Suppression of Endothelial Kir Channels Is a Driver of Impairment of Arteriolar Flow-Induced Vasodilation in Humans.

Authors:  Sang Joon Ahn; Ibra S Fancher; Sara T Granados; Natalia F Do Couto; Chueh-Lung Hwang; Shane A Phillips; Irena Levitan
Journal:  Hypertension       Date:  2021-11-17       Impact factor: 10.190

7.  Celastrol Dilates and Counteracts Ethanol-Induced Constriction of Cerebral Arteries.

Authors:  Kelsey North; Alexandria Slayden; Steven Mysiewicz; Anna Bukiya; Alex Dopico
Journal:  J Pharmacol Exp Ther       Date:  2020-08-29       Impact factor: 4.030

8.  Ethinyl estradiol-to-desogestrel ratio impacts endothelial function in young women.

Authors:  Jessica R Meendering; Britta N Torgrimson; Nicole P Miller; Paul F Kaplan; Christopher T Minson
Journal:  Contraception       Date:  2008-10-28       Impact factor: 3.375

9.  Endothelial function, endothelin-1, and fibrinogen in young women using the vaginal contraceptive ring.

Authors:  Britta N Torgrimson; Jessica R Meendering; Nicole P Miller; Paul F Kaplan; Christopher T Minson
Journal:  Fertil Steril       Date:  2008-08-15       Impact factor: 7.329

Review 10.  Winter Hypertension: Potential mechanisms.

Authors:  Auda Fares
Journal:  Int J Health Sci (Qassim)       Date:  2013-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.